The AML Content Hub Channel

Targeted Therapy for Acute Myeloid Leukemia

3:55 | AML Content Hub, Oncology, Oncology / Hematology

Can targeted therapies offer safer and more efficient means to treat patients with acute myeloid leukemia (AML)? Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center in Buffalo, NY, shares a brief overview of AML and discusses how the treatment landscape for patients with AML has changed in recent years.

Click here to learn more.

More in AML Content Hub

► 1:24

New Strategies for Cytopenia Management in MDS

AML Content Hub

In an interview conducted during the 2021 European School of Hematology (ESH) 7th Translational Research E-Conference on Myelodysplastic Syndromes, Uwe Platzbecker, MD, Director of the Medical Clinic I at the...

► 1:22

The Immunological Impact of TP53 in Patients With MDS

AML Content Hub

In an interview conducted during the 2021 European School of Hematology (ESH) 7th Translational Research E-Conference on Myelodysplastic Syndromes, Shahram Kordasti, MD, PhD, King's College London, London, UK, discusses TP53...

► 3:56

The Impact of Genetics on Treatment for Patients With MDS

AML Content Hub

During the virtual European Hematology Association (EHA) Congress 2021, Valeria Santini, MD, an associate professor of hematology at the University of Florence, in Florence, Italy, discusses the genomic landscape of...

► 2:36

Earlier AML Detection

AML Content Hub

In an interview conducted at the 2021 ASCO Annual Meeting, Chris Hourigan, MD, DPhil, National Institutes of Health, Bethesda, Maryland, discusses earlier detection of AML. Among patients who initially respond...